| Amrubicin studied in …STUDIED_INderived22 of 22show fewer |
|---|
| → studied in | NCT07365241Phase 3 · recruiting A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer · 22 trials list this drug (4 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06801834Phase 3 · recruiting Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer · 22 trials list this drug (4 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06203210Phase 3 · recruiting A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer · 22 trials list this drug (4 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05740566Phase 3 · active not recruiting Study Comparing Tarlatamab With Standard of Care Chemotherapy in Relapsed Small Cell Lung Cancer · 22 trials list this drug (4 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01904253Phase 2 · terminated A Phase 2 Study Comparing TAS-102 Versus Topotecan or Amrubicin to Treat Small Cell Lung Cancer Following Platinum-Based Chemotherapy · 22 trials list this drug (4 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02481830Phase 3 · completed Effectiveness Study of Nivolumab Compared to Chemotherapy in Patients With Relapsed Small-cell Lung Cancer · 22 trials list this drug (4 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01033032Phase 1/Phase 2 · completed Trial of Amrubicin as Treatment for Patients With HER2-Negative Metastatic Breast Cancer · 22 trials list this drug (4 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00286169Phase 3 · terminated Amrubicin Study for Elderly Patients With Extensive-disease Small-cell Lung Cancer (ED-SCLC) · 22 trials list this drug (4 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00388960Phase 2 · completed Study of Amrubicin With or Without Cisplatin Versus Etoposide-cisplatin for Extensive Stage Small Cell Lung Cancer · 22 trials list this drug (4 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00547651Phase 3 · completed AMR PH GL 2007 CL001 Phase 3 Trial in Patients With Small Cell Lung Cancer After Failure of First-Line Chemotherapy · 22 trials list this drug (4 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00915083Phase 1 · completed A Phase I Study to Assess the Safety, Pharmacokinetics, and Potential Effects of Amrubicin on the QT/QTc Interval in Cancer Patients With Advanced Solid Tumors. · 22 trials list this drug (4 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00375193Phase 2 · completed Study of Amrubicin in Patients With Small Cell Lung Cancer Refractory or Progressive to Prior Therapy · 22 trials list this drug (4 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01364727Phase 2 · completed A Phase 2 Study of Amrubicin in Relapsed or Refractory Thymic Malignancies · 22 trials list this drug (4 active) | — | — | Malignant Thymus Neoplasm,Thymoma,Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01355705Phase 1/Phase 2 · completed Phase 1-2 Amrubicin in Combo With Lenalidomide + Weekly Dexamethasone in Relapsed/Refractory Multiple Myeloma · 22 trials list this drug (4 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01331824Phase 2 · terminated Trial of Amrubicin as Second-Line Therapy in Patients With Advanced/Metastatic Refractory Urothelial Carcinoma · 22 trials list this drug (4 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01259375Phase 2 · completed Amrubicin Chemotherapy as First Line in Metastatic or Unresectable Soft Tissue Sarcoma · 22 trials list this drug (4 active) | — | — | Soft Tissue Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01076504Phase 2 · completed A Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer · 22 trials list this drug (4 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00890955Phase 1 · completed Amrubicin + Cyclophosphamide in Advanced Solid Organ Malignancies · 22 trials list this drug (4 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00660504Phase 3 · completed Phase3 Study of Amrubicin With Cisplatin Versus Etoposide-cisplatin for Extensive Disease Small Cell Lung Cancer · 22 trials list this drug (4 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00132054Phase 1 · completed Amrubicin and Irinotecan in Treating Patients With Recurrent or Relapsed Extensive Stage Small Cell Lung Cancer · 22 trials list this drug (4 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00319969Phase 2 · completed Study Comparing Amrubicin Versus Topotecan in Patients With Small Cell Lung Cancer Who Have Responded to Prior Therapy. · 22 trials list this drug (4 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00380835Phase 2 · withdrawn Study of Amrubicin With or Without Herceptin in Patients With Metastatic Breast Cancer · 22 trials list this drug (4 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |